Efficacy and Safety of Treatment with Quadruple Oral Hypoglycemic Agents in Uncontrolled Type 2 Diabetes Mellitus: A Multi-Center, Retrospective, Observational Study
Jun Sung Moon (Moon JS), Sunghwan Suh (Suh S), Sang Soo Kim (Kim SS), Heung Yong Jin (Jin HY), Jeong Mi Kim (Kim JM), Min Hee Jang (Jang MH), Kyung Ae Lee (Lee KA), Ju Hyung Lee (Lee JH), Seung Min Chung (Chung SM), Young Sang Lyu (Lyu YS), Jin Hwa Kim (Kim JH), Sang Yong Kim (Kim SY), Jung Eun Jang (Jang JE), Tae Nyun Kim (Kim TN), Sung Woo Kim (Kim SW), Eonju Jeon (Jeon E), Nan Hee Cho (Cho NH), Mi-Kyung Kim (Kim MK), Hye Soon Kim (Kim HS), Il Seong Nam-Goong (Nam-Goong IS), Eun Sook Kim (Kim ES), Jin Ook Chung (Chung JO), Dong-Hyeok Cho (Cho DH), Chang Won Lee (Lee CW), Young Il Kim (Kim YI), Dong Jin Chung (Chung DJ), Kyu Chang Won (Won KC), In Joo Kim (Kim IJ), Tae Sun Park (Park TS), Duk Kyu Kim (Kim DK), Hosang Shon (Shon H)
Diabetes Metab J. 2021;45(5):675-683.   Published online 2020 Aug 12     DOI: https://doi.org/10.4093/dmj.2020.0107
Citations to this article as recorded by Crossref logo
Effectiveness and safety of teneligliptin added to patients with type 2 diabetes inadequately controlled by oral triple combination therapy: A multicentre, randomized, double‐blind, and placebo‐controlled study
Minyoung Lee, Woo‐je Lee, Jae Hyeon Kim, Byung‐Wan Lee
Diabetes, Obesity and Metabolism.2022; 24(6): 1105.     CrossRef
A double‐blind, Randomized controlled trial on glucose‐lowering EFfects and safety of adding 0.25 or 0.5 mg lobeglitazone in type 2 diabetes patients with INadequate cont
Soree Ryang, Sang Soo Kim, Ji Cheol Bae, Ji Min Han, Su Kyoung Kwon, Young Il Kim, Il Seong Nam‐Goong, Eun Sook Kim, Mi‐kyung Kim, Chang Won Lee, Soyeon Yoo, Gwanpyo Koh, Min Jeong Kwon, Jeong Hyun Park, In Joo Kim
Diabetes, Obesity and Metabolism.2022; 24(9): 1800.     CrossRef